Implementation of mMINDS monitoring for alcohol withdrawal at an inpatient academic psychiatric facility
Introduction Patients who abruptly stop the consumption of alcohol are at risk of alcohol withdrawal syndrome (AWS). Guidelines recommend the use of a validated clinical withdrawal scoring tool to assess the severity of a patient’s withdrawal. The modified Minnesota Detoxification Scale (mMINDS) pro...
Saved in:
| Main Authors: | Leah A. Surbaugh, PharmD, BCPP, Taylor Kelsey, PharmD, BCPP, Brittany L. Melton, PharmD, PhD, Karen E. Moeller, PharmD, BCPP |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association of Psychiatric Pharmacists
2025-08-01
|
| Series: | Mental Health Clinician |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.08.201 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
by: Maxwell Lamb, PharmD, BCPS, et al.
Published: (2025-06-01) -
Review of acamprosate pharmacokinetics and dosing strategies
by: Lauren Steil, PharmD, et al.
Published: (2025-04-01) -
Trazodone versus doxepin as a pharmacologic sleep aid in psychiatric inpatients: A retrospective cohort study
by: Kevin Chen, PharmD, et al.
Published: (2025-04-01) -
Phosphatidylethanol levels and their association with withdrawal severity among individuals with severe alcohol use disorder seeking inpatient withdrawal management
by: Jeong Hoo Lee, et al.
Published: (2025-06-01) -
Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01)